GSK481 is a Mono-Selective RIP1 Kinase Inhibitor
Recent research shows that RIP1 kinase activity is an important driver of TNF-mediated inflammation and pathology. Genetic evidence of mice supports it. The mutations shunt signaling down the RIP1 kinase…